Sun Pharmaceutical Industries Ltd PE Ratio

Sun Pharmaceutical Industries PE Ratio

Image

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

PE

34.9

Last updated on: Sep 19, 2026

Key Highlights

  • The P/E Ratio of Sun Pharmaceutical Industries Ltd is 34.9 as of 19 Sep 15:30 PM The P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 49.4 on March 2021 to 36.7 on March 2026 . This represents a CAGR of -4.83% over 6 years The Latest Trading Price of Sun Pharmaceutical Industries Ltd is ₹ 1835 as of 18 Sep 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.4 in 5 years. This represents a CAGR of 5.66% The PE Ratio of Automobile industry is 12.7. The PE Ratio of Finance industry is 16.5. The PE Ratio of IT - Software industry is 18.5. The PE Ratio of Pharmaceuticals industry is 31.7. The PE Ratio of Retail industry is 88.6. The PE Ratio of Textiles industry is 36.7 in 2026 .

Historical P/E Ratio of Sun Pharmaceutical Industries Ltd

No data available

Company Fundamentals for Sun Pharmaceutical Industries Ltd

Image

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

Share Price

₹ 1835.5

-30.50 (-1.63%)

stock direction

Last updated on: Sep 18, 2026

Market Price of Sun Pharmaceutical Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceutical Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
18 Sep 20261835.5
17 Sep 20261866
16 Sep 20261853.5
15 Sep 20261835
11 Sep 20261842
10 Sep 20261864
09 Sep 20261868.5
08 Sep 20261881.1
07 Sep 20261899.8
04 Sep 20261899

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Sun Pharmaceutical Industries Ltd

Asset Value vs Market Value of Sun Pharmaceutical Industries Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sun Pharmaceutical Industries Ltd440397
Divis Laboratories Ltd248664
Torrent Pharmaceuticals Ltd182738
Zydus Lifesciences Ltd115012
Cipla Ltd110794
Laurus Labs Ltd105645

PE Ratio of Sun Pharmaceutical Industries Ltd Explained

440397

Market cap

12095

Earnings

34.9X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharmaceutical Industries Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sun Pharmaceutical Industries Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharmaceutical Industries Ltd

No data available

* All values are in %

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Sun Pharmaceutical Industries Ltd News Hub

Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a

Read more

20 Aug 24

Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.

Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant

Read more

14 Aug 24

Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr

Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D

Read more

01 Aug 24

Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju

Read more

01 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions